
ICICI Pru Nifty Pharma Index Fund-Reg (G)
Equity · Index
22.47%
Last 1 year
- Exit Load
- 0.00%
- Expense Ratio
- 1.13%
- Min. AmountMin. SIP Amount
- ₹1,000
- Min. Lump SumMin. Lump sum
- ₹1,000
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹12,51,483
- IRR
- 20.553%
- Absolute Gain
- +₹3,51,483 (+39.1%)
Returns & Rankings
Category: Equity Index


346 ProductsEquity Index Funds


346 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 22.5%
- 3Y Returns
- 20.6%
- Alpha
- -1.19
Holding Analysis
Equity/Debt/Cash Split
- Equity99.9%
- Debt0.1%
Market Cap Weightage
- Large Cap58%
- Mid Cap38.9%
- Small Cap3%
- Others0.1%
Sector allocation
- Healthcare99.9%
- Debt0.1%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Sun Pharma.Inds. | Pharmaceuticals | 18.6% |
| Divi's Lab. | Pharmaceuticals | 12.28% |
| Laurus Labs | Pharmaceuticals | 9.26% |
| Dr Reddy's Labs | Pharmaceuticals | 8.15% |
| Cipla | Pharmaceuticals | 7.67% |
| Torrent Pharma. | Pharmaceuticals | 6.71% |
| Lupin | Pharmaceuticals | 4.83% |
| Aurobindo Pharma | Pharmaceuticals | 4.59% |
| Glenmark Pharma. | Pharmaceuticals | 3.42% |
| Zydus Lifesci. | Pharmaceuticals | 3.05% |
- 18.6%
Sun Pharma.Inds.
Pharmaceuticals
- 12.28%
Divi's Lab.
Pharmaceuticals
- 9.26%
Laurus Labs
Pharmaceuticals
- 8.15%
Dr Reddy's Labs
Pharmaceuticals
- 7.67%
Cipla
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 22.47% | 20.55% | |
| — | Equity | 1.22% | 17.82% | |
| — | Equity | 2.54% | 17.77% | |
| — | Equity | -2.41% | 17.76% | |
| — | Equity | 3.15% | 16.17% |
Peer Comparison
ICICI Pru Nifty Pharma Index Fund-Reg (G)
- 1 Y Return
- 22.47%
- 3 Y Return
- 20.55%
- 5 Y Return
- —
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Fund Management

Nishit Patel
Mr. Nishit joined ICICI Prudential Asset Management Company Limited in November 2018. Past Experience: ICICI Prudential Asset Management Company Limited - ETF Business - November 2018 - January 2020.
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- -1.19
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 1.00
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.98
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 15.70
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.13
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 49.30
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
ICICI Pru Nifty Pharma Index Fund-Reg – Regular Plan - Growth was launched 3 years ago and has delivered annualised returns (CAGR) of 21.16% since inception. Here are its returns over time:
Period Fund 1 Year 22.47% 3 Years 20.55% Since Inception 21.16% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of ICICI Pru Nifty Pharma Index Fund-Reg – Regular Plan - Growth is 1.13%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
ICICI Pru Nifty Pharma Index Fund-Reg is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in ICICI Pru Nifty Pharma Index Fund-Reg with ₹1,000 a month, or invest a lump sum of ₹1,000. Additional investments start at ₹1,000.
ICICI Pru Nifty Pharma Index Fund-Reg has no exit load.
No, ICICI Pru Nifty Pharma Index Fund-Reg has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
ICICI Pru Nifty Pharma Index Fund-Reg manages assets (AUM) of approximately ₹177 Cr.
As on 31 Oct 2026, ICICI Pru Nifty Pharma Index Fund-Reg holds 22 securities. These are its top 10 holdings:
Company % of portfolio Sun Pharma.Inds. 18.60% Divi's Lab. 12.28% Laurus Labs 9.26% Dr Reddy's Labs 8.15% Cipla 7.67% Torrent Pharma. 6.71% Lupin 4.83% Aurobindo Pharma 4.59% Glenmark Pharma. 3.42% Zydus Lifesci. 3.05% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 99.90% Debt 0.10% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the ICICI Prudential Mutual Fund website, MF Central or CAMS. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












